Xinyang Yu and colleagues used palmitic acid and lipopolysaccharide to stimulate HepG2 cells to establish a NASH model to assess the role of liraglutide, NLRP3 inflammasome and mitophagy in NASH. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.